drugset

drugset / Trial / NCT06933459

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults

NCT06933459 ↗

Phase 1 Active not recruiting 60 enrolled AJU Pharm Co., Ltd.

RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the safety and pharmacokinetic characteristics of AJU-C714 and C714R in healthy adults

Timeline

Start: 2025-05-24
Primary completion: 2025-06-11
Completion: 2025-06-24

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AJU-C714	Unknown	—	—
Subject	C714R	Unknown	—	—

Indications